OpenURL Connection Search

Select item for more details and to access through your institution.

ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma – the Nordic Lymphoma Group experience.
Published in:
European Journal of Haematology, 2004, v. 73, n. 3, p. 179, doi. 10.1111/j.1600-0609.2004.00294.x
By:
- Jerkeman, M.;
- Leppä, S.;
- Kvaløy, S.;
- Holte, H.
Publication type:
Article
Prognostic implications of cytogenetic aberrations in diffuse large B-cell lymphomas.
Published in:
European Journal of Haematology, 1999, v. 62, n. 3, p. 184, doi. 10.1111/j.1600-0609.1999.tb01742.x
By:
- Jerkeman, M.;
- Johansson, B.;
- Åkerman, M.;
- Cavallin-Ståhl, E.;
- Kristoffersson, U.;
- Mitelman, F.
Publication type:
Article
Myocardial infarction in diffuse large B‐cell lymphoma patients – a population‐based matched cohort study.
Published in:
Journal of Internal Medicine, 2021, v. 290, n. 5, p. 1048, doi. 10.1111/joim.13303
By:
- Ekberg, S.;
- Harrysson, S.;
- Jernberg, T.;
- Szummer, K.;
- Andersson, P.‐O.;
- Jerkeman, M.;
- Smedby, K. E.;
- Eloranta, S.
Publication type:
Article
Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B-cell lymphoma: a Swedish lymphoma register study.
Published in:
2019
By:
- Wästerlid, T.;
- Mohammadi, M.;
- Smedby, K. E.;
- Glimelius, I.;
- Jerkeman, M.;
- Bottai, M.;
- Eloranta, S.
Publication type:
journal article
Targeting of B-cell receptor signalling in B-cell malignancies.
Published in:
2017
By:
- Jerkeman, M.;
- Hallek, M.;
- Dreyling, M.;
- Thieblemont, C.;
- Kimby, E.;
- Staudt, L.
Publication type:
journal article
Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma—a Nordic Lymphoma Group study.
Published in:
Annals of Hematology, 2004, v. 83, n. 7, p. 414, doi. 10.1007/s00277-004-0855-x
By:
- Jerkeman, M.;
- Anderson, H.;
- Dictor, M.;
- Kvaløy, S.;
- Åkerman, M.;
- Cavallin-Ståhl, E.
Publication type:
Article
A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia.
Published in:
NPJ Precision Oncology, 2018, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41698-018-0061-2
By:
- Ljungars, A.;
- Mårtensson, L.;
- Mattsson, J.;
- Kovacek, M.;
- Sundberg, A.;
- Tornberg, U-C.;
- Jansson, B.;
- Persson, N.;
- Emruli, V. Kuci;
- Ek, S.;
- Jerkeman, M.;
- Hansson, M.;
- Juliusson, G.;
- Ohlin, M.;
- Frendéus, B.;
- Teige, I.;
- Mattsson, M.
Publication type:
Article
Trends in survival after cardiac arrest: A Swedish nationwide study over 30 years.
Published in:
Cardiology Research Review, 2022, n. 101, p. 4
By:
- M., Jerkeman
Publication type:
Article
PHASE 1/2A CLINICAL TRIAL OF BI‐1206, A MONOCLONAL ANTIBODY TO CD32B (FCGRIIB), IN COMBINATION WITH RITUXIMAB IN SUBJECTS WITH INDOLENT B‐CELL LYMPHOMA.
Published in:
Hematological Oncology, 2023, v. 41, p. 835, doi. 10.1002/hon.3166_OT16
By:
- Jerkeman, M.;
- Costa, P. Abrisqueta;
- Hagberg, H. E.;
- Cia, J. M. Sancho;
- Bastos‐Oreiro, M.;
- Stevens, D.;
- Cohen, J. B;
- Mascunano, R. Cordoba;
- Domenech, E. Domingo;
- Román, I. Fernández;
- Canales, S. Novelli;
- Borggren, M.;
- Frendeus, B.;
- Karlsson, I.;
- Mårtensson, L.;
- Patel, S.;
- Teige, I.;
- Wallin, J. E.;
- Allister, A. Mc
Publication type:
Article
SOLUBLE MACROPHAGE MARKER SCD163 PREDICTS OUTCOME IN BOTH CHEMOIMMUNOTHERAPY AND TARGETED THERAPY TREATED MANTLE CELL LYMPHOMA.
Published in:
Hematological Oncology, 2023, v. 41, p. 746, doi. 10.1002/hon.3165_597
By:
- Nikkarinen, A.;
- Lokhande, L.;
- Amini, R.;
- Jerkeman, M.;
- Porwit, A.;
- Molin, D.;
- Enblad, G.;
- Kolstad, A.;
- Räty, R.;
- Hutchings, M.;
- Weibull, C. E.;
- Hollander, P.;
- Ek, S.;
- Glimelius, I.
Publication type:
Article
HYPOGAMMAGLOBULINEMIA AT DIAGNOSIS IS ASSOCIATED WITH INFERIOR SURVIVAL AND HIGHER RISK OF INFECTIONS IN DIFFUSE LARGE B CELL LYMPHOMA: A RETROSPECTIVE STUDY FROM SWEDEN.
Published in:
Hematological Oncology, 2023, v. 41, p. 726, doi. 10.1002/hon.3165_578
By:
- Lindberg, Å.;
- Johansson, Å.;
- Kahn, F.;
- Jönsson, G.;
- Cederwall, S.;
- Jerkeman, M.
Publication type:
Article
Multicohort Study of Conditional Survival and Cause of Death After Achieving Event‐Free Survival at 24 Months (EFS24) in Patients With Mantle Cell Lymphoma (MCL).
Published in:
Hematological Oncology, 2023, v. 41, p. 472, doi. 10.1002/hon.3164_347
By:
- Wang, Y.;
- Larson, M. C.;
- Ekberg, S.;
- Smedby, K. E.;
- Zhao, E. J.;
- Gerrie, A. S.;
- Farooq, U.;
- Maurer, M. J.;
- Paludo, J.;
- Nowakowski, G. S.;
- Habermann, T. M.;
- Albertsson‐Lindblad, A.;
- Glimelius, I.;
- Link, B. K.;
- Diego, V.;
- Jerkeman, M.;
- Cerhan, J. R.
Publication type:
Article
Enhanced ctDNA Profiling Reveals Molecular Determinants of Response and Resistance in Relapsed and Refractory Mantle Cell Lymphoma (NLG‐MCL7‐VALERIA).
Published in:
Hematological Oncology, 2023, v. 41, p. 477, doi. 10.1002/hon.3164_351
By:
- Meriranta, L.;
- Kolstad, A.;
- Hutchings, M.;
- Pasanen, A.;
- Niemann, C. Utoft;
- Riise, J.;
- Christensen, J. Haaber;
- Wader, K. Fahl;
- Glimelius, I.;
- Leppä, S.;
- Jerkeman, M.
Publication type:
Article
Secondary malignancies in mantle cell lymphoma patients—A nationwide population‐based study in Sweden.
Published in:
Hematological Oncology, 2023, v. 41, p. 475, doi. 10.1002/hon.3164_349
By:
- Abalo, K.;
- Smedby, K. E.;
- Ekberg, S.;
- Eloranta, S.;
- Pahnke, S.;
- Albertsson‐Lindblad, A.;
- Jerkeman, M.;
- Glimelius, I.
Publication type:
Article
How to choose between curative radiotherapy or chemotherapy in low stage MCL?—a population‐based analysis of outcome in patients with stage I‐II MCL in Sweden.
Published in:
Hematological Oncology, 2023, v. 41, p. 476, doi. 10.1002/hon.3164_350
By:
- Albertsson‐Lindblad, A.;
- Ekberg, S.;
- Glimelius, I.;
- Ellin, F.;
- Sonnevi, K.;
- Lewerin, C.;
- Smedby, K. E.;
- Jerkeman, M.
Publication type:
Article
Trends in relative survival of Diffuse large B‐cell lymphoma in Sweden in the era of targeted and cellular therapies.
Published in:
Hematological Oncology, 2023, v. 41, p. 429, doi. 10.1002/hon.3164_316
By:
- Smedby, K. Ekström;
- Antonilli, S.;
- Enblad, G.;
- Sonnevi, K.;
- Wahlin, B. E.;
- Andersson, P.;
- Jerkeman, M.;
- Eloranta, S.
Publication type:
Article
HIGH RISK AGGRESSIVE B‐CELL LYMPHOMA ON THE LIQUID BIOPSY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.4_2880
By:
- Meriranta, L;
- Alkodsi, A;
- Pasanen, A;
- Lepistö, M;
- Blaker, Y. N;
- Jørgensen, J;
- Mapar, P;
- Björkholm, M;
- Jerkeman, M;
- Holte, H;
- Pitkänen, E;
- Ellonen, P;
- Leppä, S
Publication type:
Article
YOUNG HIGH RISK PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA INCLUDING BCL‐2/MYC DOUBLE HIT LYMPHOMAS BENEFIT FROM DOSE‐DENSE IMMUNOCHEMOTHERAPY WITH EARLY CNS PROPHYLAXIS.
Published in:
Hematological Oncology, 2019, v. 37, p. 132, doi. 10.1002/hon.92_2629
By:
- Leppä, S.;
- Jørgensen, J.;
- Tierens, A.;
- Meriranta, L.;
- Østlie, I.;
- Brown, P.;
- Fagerli, U.;
- Larsen, T.S.;
- Mannisto, S.;
- Munksgaard, L.;
- Maisenhølder, M.;
- Vasala, K.;
- Meyer, P.;
- Jerkeman, M.;
- Björkholm, M.;
- Fluge, Ø.;
- Jyrkkiö, S.;
- Ralfkiaer, E.;
- Spetalen, S.;
- Karjalainen‐Lindsberg, M.
Publication type:
Article
SERUM BIOMARKERS ARE ASSOCIATED WITH TREATMENT RESPONSE IN RELAPSED MANTLE CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 403, doi. 10.1002/hon.72_2631
By:
- Lokhande, L.;
- Emruli, V.K.;
- Kolstad, A.;
- Hutchings, M.;
- Räty, R.;
- Rodrigues, J.D.;
- Jerkeman, M.;
- Ek, S.
Publication type:
Article
THE IMMUNE MICROENVIRONMENT AS A PROGNOSTIC TOOL FOR MCL PATIENTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 344, doi. 10.1002/hon.6_2631
By:
- Rodrigues, J.M.;
- Freiburghaus, C.;
- Carlsson, A.;
- Husby, S.;
- Eskelund, C.W.;
- Lokhande, L.;
- Kolstad, A.;
- Grønbæk, K.;
- Jerkeman, M.;
- Ek, S.
Publication type:
Article
EARLY PROGRESSION OF MANTLE CELL LYMPHOMA DEPICTS A HIGH‐RISK DISEASE WITH POOR RESPONSE TO SUBSEQUENT THERAPIES AND A DISMAL OUTCOME.
Published in:
Hematological Oncology, 2019, v. 37, p. 242, doi. 10.1002/hon.52_2630
By:
- Eskelund, C.W.;
- Kolstad, A.;
- Glimelius, I.;
- Räty, R.;
- Gjerdrum, L.R.;
- Sonnevi, K.;
- Josefsson, P.;
- Nilsson‐Ehle, H.;
- Bentzen, H.;
- Fagerli, U.;
- Kuittinen, O.;
- Haaber, J.;
- Pedersen, L.B.;
- Larsen, M.T.;
- Geisler, C.H.;
- Hutchings, M.;
- Jerkeman, M.;
- Grønbæk, K.
Publication type:
Article
EVOLUTION OF CLONAL HEMATOPOIESIS IN MANTLE CELL LYMPHOMA PATIENTS BEFORE, DURING, AND AFTER INDUCTION CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION.
Published in:
Hematological Oncology, 2019, v. 37, p. 239, doi. 10.1002/hon.50_2630
By:
- Husby, S.;
- Eskelund, C.W.;
- Favero, F.;
- Rodriguez‐Gonzalez, F.G.;
- Kolstad, A.;
- Pedersen, L.B.;
- Räty, R.;
- Geisler, C.H.;
- Jerkeman, M.;
- Weischenfeldt, J.;
- Grønbæk, K.
Publication type:
Article
PHASE 1/2A CLINICAL TRIALS OF BI‐1206, A MONOCLONAL ANTIBODY TO FCΓRIIB, ADMINISTERED AS A SINGLE AGENT OR IN COMBINATION WITH RITUXIMAB IN SUBJECTS WITH B‐CELL MALIGNANCIES.
Published in:
Hematological Oncology, 2019, v. 37, p. 520, doi. 10.1002/hon.206_2631
By:
- Karlsson, I.;
- Traub, S.;
- Järås, K.;
- Edwards, D.;
- Gramming, E.;
- Lindell Andersson, M.;
- To, Y.;
- Mårtensson, L.;
- Teige, I.;
- Acton, G.;
- Dyer, M.J.;
- Radford, J.;
- Collins, G.P.;
- Jerkeman, M.;
- Frendéus, B.;
- McAllister, A.;
- Davies, A.
Publication type:
Article
YOUNG HIGH RISK PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA INCLUDING BCL‐2/MYC DOUBLE HIT LYMPHOMAS BENEFIT FROM DOSE‐DENSE IMMUNOCHEMOTHERAPY WITH EARLY CNS PROPHYLAXIS.
Published in:
Hematological Oncology, 2019, v. 37, p. 132, doi. 10.1002/hon.92_2629
By:
- Leppä, S.;
- Jørgensen, J.;
- Tierens, A.;
- Meriranta, L.;
- Østlie, I.;
- Brown, P.;
- Fagerli, U.;
- Larsen, T.S.;
- Mannisto, S.;
- Munksgaard, L.;
- Maisenhølder, M.;
- Vasala, K.;
- Meyer, P.;
- Jerkeman, M.;
- Björkholm, M.;
- Fluge, Ø.;
- Jyrkkiö, S.;
- Ralfkiaer, E.;
- Spetalen, S.;
- Karjalainen‐Lindsberg, M.
Publication type:
Article
SERUM BIOMARKERS ARE ASSOCIATED WITH TREATMENT RESPONSE IN RELAPSED MANTLE CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 403, doi. 10.1002/hon.72_2631
By:
- Lokhande, L.;
- Emruli, V.K.;
- Kolstad, A.;
- Hutchings, M.;
- Räty, R.;
- Rodrigues, J.D.;
- Jerkeman, M.;
- Ek, S.
Publication type:
Article
THE IMMUNE MICROENVIRONMENT AS A PROGNOSTIC TOOL FOR MCL PATIENTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 344, doi. 10.1002/hon.6_2631
By:
- Rodrigues, J.M.;
- Freiburghaus, C.;
- Carlsson, A.;
- Husby, S.;
- Eskelund, C.W.;
- Lokhande, L.;
- Kolstad, A.;
- Grønbæk, K.;
- Jerkeman, M.;
- Ek, S.
Publication type:
Article
EVOLUTION OF CLONAL HEMATOPOIESIS IN MANTLE CELL LYMPHOMA PATIENTS BEFORE, DURING, AND AFTER INDUCTION CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION.
Published in:
Hematological Oncology, 2019, v. 37, p. 239, doi. 10.1002/hon.50_2630
By:
- Husby, S.;
- Eskelund, C.W.;
- Favero, F.;
- Rodriguez‐Gonzalez, F.G.;
- Kolstad, A.;
- Pedersen, L.B.;
- Räty, R.;
- Geisler, C.H.;
- Jerkeman, M.;
- Weischenfeldt, J.;
- Grønbæk, K.
Publication type:
Article
EARLY PROGRESSION OF MANTLE CELL LYMPHOMA DEPICTS A HIGH‐RISK DISEASE WITH POOR RESPONSE TO SUBSEQUENT THERAPIES AND A DISMAL OUTCOME.
Published in:
Hematological Oncology, 2019, v. 37, p. 242, doi. 10.1002/hon.52_2630
By:
- Eskelund, C.W.;
- Kolstad, A.;
- Glimelius, I.;
- Räty, R.;
- Gjerdrum, L.R.;
- Sonnevi, K.;
- Josefsson, P.;
- Nilsson‐Ehle, H.;
- Bentzen, H.;
- Fagerli, U.;
- Kuittinen, O.;
- Haaber, J.;
- Pedersen, L.B.;
- Larsen, M.T.;
- Geisler, C.H.;
- Hutchings, M.;
- Jerkeman, M.;
- Grønbæk, K.
Publication type:
Article
PHASE 1/2A CLINICAL TRIALS OF BI‐1206, A MONOCLONAL ANTIBODY TO FCΓRIIB, ADMINISTERED AS A SINGLE AGENT OR IN COMBINATION WITH RITUXIMAB IN SUBJECTS WITH B‐CELL MALIGNANCIES.
Published in:
Hematological Oncology, 2019, v. 37, p. 520, doi. 10.1002/hon.206_2631
By:
- Karlsson, I.;
- Traub, S.;
- Järås, K.;
- Edwards, D.;
- Gramming, E.;
- Lindell Andersson, M.;
- To, Y.;
- Mårtensson, L.;
- Teige, I.;
- Acton, G.;
- Dyer, M.J.;
- Radford, J.;
- Collins, G.P.;
- Jerkeman, M.;
- Frendéus, B.;
- McAllister, A.;
- Davies, A.
Publication type:
Article
IBRUTINIB VS TEMSIROLIMUS: THREE-YEAR FOLLOW-UP OF PATIENTS WITH PREVIOUSLY TREATED MANTLE CELL LYMPHOMA FROM THE PHASE 3, INTERNATIONAL, RANDOMIZED, OPEN-LABEL RAY STUDY.
Published in:
Hematological Oncology, 2017, v. 35, p. 143, doi. 10.1002/hon.2437_133
By:
- Rule, S.;
- Jurczak, W.;
- Jerkeman, M.;
- Santucci Silva, R.;
- Rusconi, C.;
- Trneny, M.;
- Offner, F.;
- Caballero, D.;
- Joao, C.;
- Witzens ‐ Harig, M.;
- Hess, G.;
- Bence ‐ Bruckler, I.;
- Cho, S.;
- Thieblemont, C.;
- Zhou, W.;
- Henninger, T.;
- Goldberg, J.D.;
- Vermeulen, J.;
- Dreyling, M.
Publication type:
Article
DOSE-DENSE CHEMOIMMUNOTHERAPY AND CNS PROPHYLAXIS IN PATIENTS WITH HIGH-RISK DLBCL: A COMPARISON OF NORDIC CRY-04 AND CHIC STUDIES.
Published in:
Hematological Oncology, 2017, v. 35, p. 199, doi. 10.1002/hon.2438_62
By:
- Leppä, S.;
- Joergensen, J.;
- Nully Brown, P.;
- Fagerli, U.;
- Larsen, T.S.;
- Janes, R.;
- Mannisto, S.;
- Munksgaard, L.;
- Maisenhölder, M.;
- Vasala, K.;
- Meyer, P.;
- Jerkeman, M.;
- Björkholm, M.;
- Fluge, Ø.;
- Jyrkkiö, S.;
- Pedersen, L.M.;
- Eriksson, M.;
- Holte, H.
Publication type:
Article
MANTLE CELL LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID TISSUE: A RETROSPECTIVE MULTICENTER OBSERVATIONAL STUDY OF THE EUROPEAN MANTLE CELL LYMPHOMA NETWORK.
Published in:
Hematological Oncology, 2017, v. 35, p. 202, doi. 10.1002/hon.2438_66
By:
- Morello, L.;
- Rattotti, S.;
- Jerkeman, M.;
- Meerten, T.;
- Krawczyk, K.;
- Moita, F.;
- Marino, D.;
- Ferrero, S.;
- Szymczyk, M.;
- Aurer, I.;
- El ‐ Galaly, T.C.;
- Di Rocco, A.;
- Carli, G.;
- Defrancesco, I.;
- Giordano, L.;
- Carlo ‐ Stella, C.;
- Dreyling, M.;
- Santoro, A.;
- Arcaini, L.
Publication type:
Article
MORTALITY RATES REMAIN INCREASED IN YOUNG PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA EVEN AFTER YEARS IN REMISSION: RESULTS FROM A NORDIC LYMPHOMA GROUP STUDY.
Published in:
Hematological Oncology, 2017, v. 35, p. 172, doi. 10.1002/hon.2438_32
By:
- Biccler, J.;
- Glimelius, I.;
- Eloranta, S.;
- Nully Brown, P.;
- Jakobsen, L.H.;
- Frederiksen, H.;
- Jerkeman, M.;
- Bøgsted, M.
Publication type:
Article
BORTEZOMIB PREVENTS DEVELOPMENT OF CYTARABINE RESISTANCE IN A MANTLE CELL LYMPHOMA IN VITRO MODEL.
Published in:
Hematological Oncology, 2017, v. 35, p. 400, doi. 10.1002/hon.2439_174
By:
- Freiburghaus, C.;
- Kuci Emruli, V.;
- Johansson, A.;
- Olsson, R.;
- Ek, F.;
- Geisler, C.H.;
- Jerkeman, M.;
- Ek, S.
Publication type:
Article
LONG-TERM SURVIVAL AND LOSS IN EXPECTANCY OF LIFE IN A POPULATION-BASED COHORT OF 7114 PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA.
Published in:
Hematological Oncology, 2017, v. 35, p. 127, doi. 10.1002/hon.2437_117
By:
- Smedby, K.E.;
- Ekberg, S.;
- Andersson, P.;
- Enblad, G.;
- Wahlin, B.E.;
- Hasselblom, S.;
- Jerkeman, M.;
- Eloranta, S.
Publication type:
Article
OUTCOME PREDICTION IN DIFFUSE LARGE B-CELL LYMPHOMA CAN BE GREATLY IMPROVED BY ALTERNATIVE USE OF CLINICAL INFORMATION: A NORDIC LYMPHOMA GROUP STUDY.
Published in:
Hematological Oncology, 2017, v. 35, p. 179, doi. 10.1002/hon.2438_40
By:
- Biccler, J.L.;
- Eloranta, S.;
- Nully Brown, P.;
- Frederiksen, H.;
- Jerkeman, M.;
- Smedby, K.E.;
- Bøgsted, M.;
- El ‐ Galaly, T.C.
Publication type:
Article
Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time--a population-based comparative study.
Published in:
2015
By:
- Glimelius, I.;
- Ekberg, S.;
- Linderoth, J.;
- Jerkeman, M.;
- Chang, E.;
- Neovius, M.;
- Smedby, K.;
- Chang, E T;
- Smedby, K E
Publication type:
journal article
Erratum to: Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time-a population-based comparative study.
Published in:
2015
By:
- Glimelius, I.;
- Ekberg, S.;
- Linderoth, J.;
- Jerkeman, M.;
- Chang, E.;
- Neovius, M.;
- Smedby, K.;
- Chang, E T;
- Smedby, K E
Publication type:
corrected article
Survival in patients with intermediate or high grade non-Hodgkin’s lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOP.
Published in:
British Journal of Cancer, 2001, v. 84, n. 3, p. 303, doi. 10.1054/bjoc.2000.1566
By:
- Messori, A;
- Vaiani, M;
- Trippoli, S;
- Rigacci, L;
- Jerkeman, M;
- Longo, G
Publication type:
Article

Found: 39